An accessory role for B cells in the IL-12-induced activation of resting mouse NK cells

Journal of Immunology

Volumn 183, Issue 6, 2009, Pages 3608-3615

  Haddad, Evette A ^a   Senger, Laura K ^a   Takei, Fumio ^a,b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL STIMULATION; DENDRITIC CELL; FEMALE; INTERFERON PRODUCTION; LYMPHOCYTE DEPLETION; MACROPHAGE; MALE; MOUSE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; WILD TYPE; ANIMAL; BIOSYNTHESIS; CELL COMMUNICATION; CELL CULTURE; CYTOLOGY; DRUG EFFECT; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOUSE MUTANT; PHYSIOLOGY; SPLEEN;

ANIMALS; B-LYMPHOCYTES; CELL COMMUNICATION; CELLS, CULTURED; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-18; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; SPLEEN;

EID: 70349333233     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901391     Document Type: Article

References (51)

1. Trinchieri, G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3: 133-146. (Pubitemid 37328691)
2. Mansouri, D., P. Adimi, M. Mirsaeidi, N. Mansouri, S. Khalilzadeh, M. R. Masjedi, P. Adimi, P. Tabarsi, M. Naderi, O. Filipe-Santos, et al. 2005. Inherited disorders of the IL-12-IFN-γ axis in patients with disseminated BCG infection. Eur. J. Pediatr. 164: 753-757.
3. Rosenzweig, S. D., and S. M. Holland. 2005. Defects in the interferon-γ and interleukin-12 pathways. Immunol. Rev. 203: 38-47.
4. Magram, J., S. E. Connaughton, R. R. Warrier, D. M. Carvajal, C. Y. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D. A. Faherty, and M. K. Gately. 1996. IL-12-deficient mice are defective in IFN γ production and type 1 cytokine responses. Immunity 4: 471-481. (Pubitemid 26354656)
5. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260: 547-549.
6. Manetti, R., P. Parronchi, M. G. Giudizi, M. P. Piccinni, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177: 1199-1204. (Pubitemid 23097410)
7. Holland, S. M. 2000. Cytokine therapy of mycobacterial infections. Adv. Intern. Med. 45: 431-452.
8. Murray, H. W., and J. Hariprashad. 1995. Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis. J. Exp. Med. 181: 387-391.
9. Brunda, M. J., L. Luistro, R. R. Warrier, R. B. Wright, B. R. Hubbard, M. Murphy, S. F. Wolf, and M. K. Gately. 1993. Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J. Exp. Med. 178: 1223-1230.
10. Colombo, M. P., and G. Trinchieri. 2002. Interleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Rev. 13: 155-168.
11. Heinzerling, L., G. Burg, R. Dummer, T. Maier, P. A. Oberholzer, J. Schultz, L. Elzaouk, J. Pavlovic, and K. Moelling. 2005. Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacy. Hum. Gene Ther. 16: 35-48.
12. Mahvi, D. M., M. B. Henry, M. R. Albertini, S. Weber, K. Meredith, H. Schalch, A. Rakhmilevich, J. Hank, and P. Sondel. 2007. Intratumoral injection of IL-12 plasmid DNA: results of a phase I/IB clinical trial. Cancer Gene Ther. 14: 717-723.
13. Wigginton, J. M., E. Gruys, L. Geiselhart, J. Subleski, K. L. Komschlies, J. W. Park, T. A. Wiltrout, K. Nagashima, T. C. Back, and R. H. Wiltrout. 2001. IFN-γ and Fas/FasL are required for the antitumor and antiangiogenic effects of IL-12/pulse IL-2 therapy. J. Clin. Invest. 108: 51-62.
14. Voest, E. E., B. M. Kenyon, M. S. O'Reilly, G. Truitt, R. J. D'Amato, and J. Folkman. 1995. Inhibition of angiogenesis in vivo by interleukin 12. J. Natl. Cancer Inst. 87: 581-586.
15. Chaudhry, U. I., T. P. Kingham, G. Plitas, S. C. Katz, J. R. Raab, and R. P. DeMatteo. 2006. Combined stimulation with interleukin-18 and CpG induces murine natural killer dendritic cells to produce IFN-γ and inhibit tumor growth. Cancer Res. 66: 10497-10504.
16. + T cells in IL-12-induced immune responses in vivo. J. Immunol. 160: 16-19.
17. Dinarello, C. A. 1999. IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J. Allergy Clin. Immunol. 103: 11-24.
18. Okamura, H., H. Tsutsi, T. Komatsu, M. Yutsudo, A. Hakura, T. Tanimoto, K. Torigoe, T. Okura, Y. Nukada, K. Hattori, et al. 1995. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378: 88-91.
19. Dinarello, C. A. 1998. Interleukin-1β, interleukin-18, and the interleukin-1β converting enzyme. Ann. NY Acad. Sci. 856: 1-11.
20. Dinarello, C. A. 2006. Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process. Am. J. Clin. Nutr. 83: 447S-455S.
21. Fehniger, T. A., M. H. Shah, M. J. Turner, J. B. VanDeusen, S. P. Whitman, M. A. Cooper, K. Suzuki, M. Wechser, F. Goodsaid, and M. A. Caligiuri. 1999. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J. Immunol. 162: 4511-4520.
22. Fantuzzi, G., D. A. Reed, and C. A. Dinarello. 1999. IL-12-induced IFN-γ is dependent on caspase-1 processing of the IL-18 precursor. J. Clin. Invest. 104: 761-767.
23. Chaix, J., M. S. Tessmer, K. Hoebe, N. Fuseri, B. Ryffel, M. Dalod, L. Alexopoulou, B. Beutler, L. Brossay, E. Vivier, and T. Walzer. 2008. Cutting edge: priming of NK cells by IL-18. J. Immunol. 181: 1627-1631.
24. Lauwerys, B. R., J. C. Renauld, and F. A. Houssiau. 1999. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18. Cytokine 11: 822-830.
25. Walzer, T., M. Dalod, S. H. Robbins, L. Zitvogel, and E. Vivier. 2005. Natural-killer cells and dendritic cells: "l'union fait la force." Blood 106: 2252-2258.
26. Moretta, A., E. Marcenaro, S. Sivori, M. Della Chiesa, M. Vitale, and L. Moretta. 2005. Early liaisons between cells of the innate immune system in inflamed peripheral tissues. Trends Immunol. 26: 668-675.
27. Gumperz, J. E. 2004. CD1d-restricted "NKT" cells and myeloid IL-12 production: an immunological crossroads leading to promotion or suppression of effective anti-tumor immune responses? J. Leukocyte Biol. 76: 307-313.
28. Chan, C. W., E. Crafton, H. N. Fan, J. Flook, K. Yoshimura, M. Skarica, D. Brockstedt, T. W. Dubensky, M. F. Stins, L. L. Lanier, et al. 2006. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat. Med. 12: 207-213.
29. Taieb, J., N. Chaput, C. Menard, L. Apetoh, E. Ullrich, M. Bonmort, M. Pequignot, N. Casares, M. Terme, C. Flament, et al. 2006. A novel dendritic cell subset involved in tumor immunosurveillance. Nat. Med. 12: 214-219.
30. Watford, W. T., M. Moriguchi, A. Morinobu, and J. J. O'Shea. 2003. The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev. 14: 361-368.
31. Airoldi, I., L. Raffaghello, C. Cocco, R. Guglielmino, S. Roncella, F. Fedeli, C. Gambini, and V. Pistoia. 2004. Heterogeneous expression of interleukin-18 and its receptor in B-cell lymphoproliferative disorders deriving from naive, germinal center, and memory B lymphocytes. Clin. Cancer Res. 10: 144-154.
32. Hart, G., L. Flaishon, and I. Shachar. 2007. IL-12 and IL-18 down-regulate B cell migration in an Ly49D-dependent manner. Eur. J. Immunol. 37: 1996-2007.
33. Thibodeaux, D. K., S. E. Hunter, K. E. Waldburger, J. L. Bliss, W. L. Trepicchio, J. P. Sypek, K. Dunussi-Joannopoulos, S. J. Goldman, and J. P. Leonard. 1999. Autocrine regulation of IL-12 receptor expression is independent of secondary IFN-γ secretion and not restricted to T and NK cells. J. Immunol. 163: 5257-5264.
34. Kato, Z., J. Jee, H. Shikano, M. Mishima, I. Ohki, H. Ohnishi, A. Li, K. Hashimoto, E. Matsukuma, K. Omoya, et al. 2003. The structure and binding mode of interleukin-18. Nat. Struct. Biol. 10: 966-971.
35. Semino, C., G. Angelini, A. Poggi, and A. Rubartelli. 2005. NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. Blood 106: 609-616. (Pubitemid 40981258)
36. Wyatt, R. M., and J. R. Dawson. 1991. Characterization of a subset of human B lymphocytes interacting with natural killer cells. J. Immunol. 147: 3381-3388.
37. Michael, A., J. J. Hackett, M. Bennett, V. Kumar, and D. Yuan. 1989. Regulation of B lymphocytes by natural killer cells: role of IFN-γ. J. Immunol. 142: 1095-1101. (Pubitemid 19067476)
38. Yuan, D. 2004. Interactions between NK cells and B lymphocytes. Adv. Immunol. 84: 1-42.
39. Lucas, M., W. Schachterle, K. Oberle, P. Aichele, and A. Diefenbach. 2007. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26: 503-517. (Pubitemid 46602996)
40. Ohteki, T., H. Tada, K. Ishida, T. Sato, C. Maki, T. Yamada, J. Hamuro, and S. Koyasu. 2006. Essential roles of DC-derived IL-15 as a mediator of inflammatory responses in vivo. J. Exp. Med. 203: 2329-2338. (Pubitemid 44498367)
41. Barr, D. P., G. T. Belz, P. C. Reading, M. Wojtasiak, P. G. Whitney, W. R. Heath, F. R. Carbone, and A. G. Brooks. 2007. A role for plasmacytoid dendritic cells in the rapid IL-18-dependent activation of NK cells following HSV-1 infection. Eur. J. Immunol. 37: 1334-1342.
42. Stober, D., R. Schirmbeck, and J. Reimann. 2001. IL-12/IL-18-dependent IFN-γ release by murine dendritic cells. J. Immunol. 167: 957-965. (Pubitemid 32660853)
43. Carson, W. E., M. E. Ross, R. A. Baiocchi, M. J. Marien, N. Boiani, K. Grabstein, and M. A. Caligiuri. 1995. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro. J. Clin. Invest. 96: 2578-2582.
44. Kloss, M., P. Decker, K. M. Baltz, T. Baessler, G. Jung, H. G. Rammensee, A. Steinle, M. Krusch, and H. R. Salih. 2008. Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA. J. Immunol. 181: 6711-6719.
45. + T cells. J. Immunol. 161: 1483-1492.
46. Baratin, M., S. Roetynck, C. Lepolard, C. Falk, S. Sawadogo, S. Uematsu, S. Akira, B. Ryffel, J. G. Tiraby, L. Alexopoulou, et al. 2005. Natural killer cell and macrophage cooperation in MyD88-dependent innate responses to Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 102: 14747-14752.
47. Lapaque, N., T. Walzer, S. Meresse, E. Vivier, and J. Trowsdale. 2009. Interactions between human NK cells and macrophages in response to Salmonella infection. J. Immunol. 182: 4339-4348.
48. Ortaldo, J. R., R. Winkler-Pickett, J. Wigginton, M. Horner, E. W. Bere, A. T. Mason, N. Bhat, J. Cherry, M. Sanford, D. L. Hodge, and H. A. Young. 2006. Regulation of ITAM-positive receptors: role of IL-12 and IL-18. Blood 107: 1468-1475.
49. Nakahira, M., H. J. Ahn, W. R. Park, P. Gao, M. Tomura, C. S. Park, T. Hamaoka, T. Ohta, M. Kurimoto, and H. Fujiwara. 2002. Synergy of IL-12 and IL-18 for IFN-γ gene expression: IL-12-induced STAT4 contributes to IFN-γ promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1. J. Immunol. 168: 1146-1153.
50. Takeda, K., Y. Hayakawa, M. Atsuta, S. Hong, L. Van Kaer, K. Kobayashi, M. Ito, H. Yagita, and K. Okumura. 2000. Relative contribution of NK and NKT cells to the anti-metastatic activities of IL-12. Int. Immunol. 12: 909-914.
51. + T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide. Blood 99: 1259-1266.